Targets hard, capital‑intensive sustainability technologies other VCs avoid, bridging solutions from developed markets into China and developing countries (energy, food, health, environment) to build traction back into developed markets. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Selective firm investing where it has an unfair advantage, running a company-creation platform with 22 EIRs and a 90+ C-suite council delivering market insights to healthcare, data+AI and cyber defense. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Venture studio and fund that co‑incubates with LifePoint executives, giving startup ventures direct access to a $50B+ health system for pilot deployment, real‑world validation, and underserved population focus. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Is dedicated to companies empowering informed, connected health consumers and building system-level resilience to improve outcomes, experiences, and lower healthcare costs. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Acts as a VC and venture studio—co-founds emerging ventures with 25–30% of capital, assembles top‑1% specialists, and builds national‑capability defense, industrials, and bio‑infrastructure companies with corporate partners. The firm continues to build its presence across the venture capital landscape.
A climate-focused agrifood fund evolved from corporate-backed to institutional VC, presenting founders rare food-policy and regulatory expertise through partner Sam Kass. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
